» Articles » PMID: 33012199

Necrosis-Released HMGB1 (High Mobility Group Box 1) in the Progressive Pulmonary Arterial Hypertension Associated With Male Sex

Overview
Journal Hypertension
Date 2020 Oct 5
PMID 33012199
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Damage-associated molecular patterns, such as HMGB1 (high mobility group box 1), play a well-recognized role in the development of pulmonary arterial hypertension (PAH), a progressive fatal disease of the pulmonary vasculature. However, the contribution of the particular type of vascular cells, type of cell death, or the form of released HMGB1 in PAH remains unclear. Moreover, although male patients with PAH show a higher level of circulating HMGB1, its involvement in the severe PAH phenotype reported in males is unknown. In this study, we aimed to investigate the sources and active forms of HMGB1 released from damaged vascular cells and their contribution to the progressive type of PAH in males. Our results showed that HMGB1 is released by either pulmonary artery human endothelial cells or human pulmonary artery smooth muscle cells that underwent necrotic cell death, although only human pulmonary artery smooth muscle cells produce HMGB1 during apoptosis. Moreover, only human pulmonary artery smooth muscle cell death induced a release of dimeric HMGB1, found to be mitochondrial reactive oxygen species dependent, and TLR4 (toll-like receptor 4) activation. The modified Sugen/Hypoxia rat model replicates the human sexual dimorphism in PAH severity (right ventricle systolic pressure in males versus females 54.7±2.3 versus 44.6±2 mm Hg). By using this model, we confirmed that necroptosis and necrosis are the primary sources of circulating HMGB1 in the male rats, although only necrosis increased circulation of HMGB1 dimers. Attenuation of necrosis but not apoptosis or necroptosis prevented TLR4 activation in males and blunted the sex differences in PAH severity. We conclude that necrosis, through the release of HMGB1 dimers, predisposes males to a progressive form of PAH.

Citing Articles

New insights into pulmonary arterial hypertension: interaction between PANoptosis and perivascular inflammatory responses.

Su X, Sun Y, Dai A Apoptosis. 2025; .

PMID: 39979525 DOI: 10.1007/s10495-025-02086-0.


Exploring the diagnostic and immune infiltration roles of disulfidptosis related genes in pulmonary hypertension.

Tan X, Zhang N, Zhang G, Xu S, Zeng Y, Bian F Respir Res. 2024; 25(1):365.

PMID: 39385167 PMC: 11465917. DOI: 10.1186/s12931-024-02978-w.


Circulating free heme induces cytokine storm and pulmonary hypertension through the MKK3/p38 axis.

Valuparampil Varghese M, James J, Bharti D, Rischard F, Rafikova O, Rafikov R Am J Physiol Lung Cell Mol Physiol. 2024; 327(4):L574-L586.

PMID: 39197168 PMC: 11482467. DOI: 10.1152/ajplung.00422.2022.


Targeting necroptosis: a promising avenue for respiratory disease treatment.

Cao X, Tan J, Zheng R, Wang F, Zhou L, Yi J Cell Commun Signal. 2024; 22(1):418.

PMID: 39192326 PMC: 11350980. DOI: 10.1186/s12964-024-01804-6.


Interleukin-6 and pulmonary hypertension: from physiopathology to therapy.

Xu W, Wu Q, He W, Wang S, Zhao Y, Huang J Front Immunol. 2023; 14:1181987.

PMID: 37449201 PMC: 10337993. DOI: 10.3389/fimmu.2023.1181987.


References
1.
Bauer E, Shapiro R, Zheng H, Ahmad F, Ishizawar D, Comhair S . High mobility group box 1 contributes to the pathogenesis of experimental pulmonary hypertension via activation of Toll-like receptor 4. Mol Med. 2012; 18:1509-18. PMC: 3576475. DOI: 10.2119/molmed.2012.00283. View

2.
Rafikov R, Nair V, Sinari S, Babu H, Sullivan J, Yuan J . Gender Difference in Damage-Mediated Signaling Contributes to Pulmonary Arterial Hypertension. Antioxid Redox Signal. 2019; 31(13):917-932. PMC: 6765065. DOI: 10.1089/ars.2018.7664. View

3.
Rafikova O, Rafikov R, Kangath A, Qu N, Aggarwal S, Sharma S . Redox regulation of epidermal growth factor receptor signaling during the development of pulmonary hypertension. Free Radic Biol Med. 2016; 95:96-111. PMC: 5929487. DOI: 10.1016/j.freeradbiomed.2016.02.029. View

4.
Dai M, Xiao R, Cai L, Ge T, Zhu L, Hu Q . HMGB1 is mechanistically essential in the development of experimental pulmonary hypertension. Am J Physiol Cell Physiol. 2018; 316(2):C175-C185. DOI: 10.1152/ajpcell.00148.2018. View

5.
Zhu Y, Cui H, Xia Y, Gan H . RIPK3-Mediated Necroptosis and Apoptosis Contributes to Renal Tubular Cell Progressive Loss and Chronic Kidney Disease Progression in Rats. PLoS One. 2016; 11(6):e0156729. PMC: 4900656. DOI: 10.1371/journal.pone.0156729. View